Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Advances in blood–brain barrier-crossing nanomedicine for anti-glioma

Fig. 7

Adapted from ref. (Scheetz et al. 2020) with permission from the American Association for Cancer Research copyright 2020; adapted from ref. (Ruan et al. 2019) with permission from the American Chemical Society copyright 2019

Chemotherapy combined with immunotherapy. a The formulation process for neoantigen-loaded sHDL nanodiscs (Scheetz et al. 2020). b Chemotherapy with D&H-A-A&C-enabled autophagic inhibition combined with PD-L1 blockade (Ruan et al. 2019).

Back to article page